| Literature DB >> 30258542 |
Alejandro Meco-Navas1, Godwin U Ebiloma2,3, Ana Martín-Domínguez1, Irene Martínez-Benayas1, Eduardo J Cueto-Díaz1, Amani Saud Alhejely2, Emmanuel O Balogun4, Machi Saito3, Miho Matsui3, Natsumi Arai3, Tomoo Shiba3, Shigeharu Harada3, Harry P de Koning2, Christophe Dardonville1.
Abstract
The SAR of 4-hydroxybenzaldehyde inhibitors of the trypanosome alternative oxidase (TAO), a critical enzyme for the respiration of bloodstream forms of trypanosomes, was investigated. Replacing the aldehyde group with a methyl ester resulted in a 10-fold increase in TAO inhibition and activity against T. brucei. Remarkably, two analogues containing the 2-hydroxy-6-methyl scaffold (9e and 16e) displayed single digit nanomolar TAO inhibition, which constitute the most potent 4-alkoxybenzoic acid derivatives described to date. 9e was 50-times more potent against TAO and 10-times more active against T. brucei compared to its benzaldehyde analogue 1. The farnesyl derivative 16e was as potent a TAO inhibitor as ascofuranone with IC50 = 3.1 nM. Similar to ascofuranone derivatives, the 2-hydroxy and 6-methyl groups seemed essential for low nanomolar TAO inhibition of acid derivatives, suggesting analogous binding interactions with the TAO active site.Entities:
Year: 2018 PMID: 30258542 PMCID: PMC6142067 DOI: 10.1021/acsmedchemlett.8b00282
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345